NMR Metabolomics Core/SNYDER
NMR Metabolomics Core/SNYDER
批准号:
8534960
负责人:
SUSAN J SUMNER
金额:
$23.36万
依托单位国家:
美国
项目类别:
财政年份:
2012
资助国家:
美国
项目状态:
未结题
起止时间:
2012-09-04 至
关键词:
AdoptedAgeBiochemical PathwayBiochemistryBiologicalBiological MarkersBiomedical ResearchBrainCell ExtractsCellsClientCodeCollaborationsComplementConsultConsultationsContractsDataData AnalysesData FilesDatabasesDepositionDetectionDiscriminant AnalysisDiseaseDoseEnsureEthnic OriginFunctional disorderFundingGenderGenerationsGrantHealthHousingHuman Subject ResearchInstructionInternshipsInterventionInvestigationKidneyLeast-Squares AnalysisLibrariesLinkLiquid substanceLiverMann-Whitney U TestMapsMass Spectrum AnalysisMeasuresMethodsMolecular WeightNMR SpectroscopyNuclear Magnetic ResonanceOnline SystemsOutcomePathway interactionsPatternPhenotypePlasmaPreparationPrincipal Component AnalysisProcessPublicationsQuality ControlRaceReproducibilityResearch DesignResearch InstituteResearch PersonnelResourcesRodent ModelSamplingScientistSerumSignal TransductionStreamStructureTestingTestisTissue ExtractsTissuesTrainingUrineUterusWorkbasecostcost effectivedata sharingexperienceinsightmeetingsmembermetabolomicsnovel strategiesnutritionoutreachprogramsresponse
中文摘要
NMR代谢组学核心将负责生成和分析生物体液和组织提取物的代谢组学图谱。该核心将通过以一致和连贯的格式提供标准化分析和数据,并提供在研究设计和其他表型指标和数据流背景下解释结果的专业知识,支持RTI RCMRC。RTI内部的研究
代谢组学计划包括样品分析(例如,尿、血清、血清提取物、血浆、肝、肾、脑、子宫、睾丸),以提供机理见解并开发预测不良健康结果的生物标志物。NMR代谢组学核心还具有评估来自人类受试者研究的样本的经验,
对治疗和疾病终点的反应。NMR代谢组学核心是由我们的合作伙伴从大卫H。默多克研究所,拥有最先进的700 MHz和950 MHz NMR光谱仪。三位国际公认的代谢组学科学家(Jeremy Nicholson博士,Elaine Holmes博士和Ian Wilson博士)将通过咨询和合作支持RTI RCMRC。这一核心
将确保采用最具成本效益的方法,对适当规模的批次进行样本分析,以降低成本。质量控制特征将包括使用内部标准品、预先确定重复测量方法的重现性、在中心活动的所有方面使用单一样品代码以及适当的稽查。核心成员将与RTI RCMRC管理团队合作,根据数据共享计划和要求以及EC,制定一致的格式和可接受的格式,以将原始数据或处理后的数据文件存款数据存储库和协调中心。NMR Core将开发和采用EC认为合适的新方法。国家监测和报告核心小组成员将与宣传和外联核心小组合作,编制在会议上分发的材料,并提供网上培训和实习培训。NMR核心将通过代谢物鉴定支持质谱核心。
英文摘要
The NMR Metabolomics Core will be responsible for the generation and analysis of metabolomic profiles of biological fluids and tissue extracts. This Core will support the RTI RCMRC by providing standardized analysis and data in a consistent and coherent format, and providing expertise for interpreting results in the context of the study design and other phenotypic measures and data streams. Studies within the RTI
Metabolomics Program have included the analysis of samples (e.g., urine, serum, extracts of serum, plasma, liver, kidney, brain, uterus, testes) from dose-response studies in rodent models to provide mechanistic insights and to develop biomarkers that are predictive of adverse health outcomes. The NMR Metabolomics Core also has experience evaluating samples from human subject research aimed at examining the
responsivity to treatment and disease endpoints. The NMR Metabolomics Core is supported by our partners from the David H. Murdock Research Institute, which houses state-of-the-art 700 MHz and 950 MHz NMR spectrometers. Three internationally recognized metabolomics scientists (Dr. Jeremy Nicholson, Dr. Elaine Holmes, and Dr. Ian Wilson) will support the RTI RCMRC though consultation and collaboration. This core
will ensure that the most cost-effective approach is used by conducting analysis of samples in appropriate size batches to reduce costs. Quality control features will include the use of internal standards, prior determination of reproducibility of methods with repeat measures, using single sample code throughout all aspects of center activities, and appropriate audits. The Core members will work with the RTI RCMRC Management Team to develop consistent formats and acceptable formats to deposit raw data or processed data files to the Data Repository and Coordinating Center according to the data sharing plan and requirements and the EC. The NMR Core will develop and adopt new methods as deemed appropriate by the EC. Members of the NMR Core will work with the Promotion and Outreach Core to develop materials for dissemination at meetings, and to provide web-based and internship training. The NMR Core will support the Mass Spectrometry Cores through metabolite identification.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Year 2, Targeted and Clinical Assay Supplement to the NPH MCAC
-
批准号:10867046
-
项目类别:
-
资助金额:$120.0万
-
财政年份:2023
-
负责人:SUSAN J SUMNER
-
依托单位:
Metabolomics and Clinical Assays Center
-
批准号:10549789
-
项目类别:
-
资助金额:$470.19万
-
财政年份:2022
-
负责人:SUSAN J SUMNER
-
依托单位:
Metabolomics and Clinical Assays Center
-
批准号:10379509
-
项目类别:
-
资助金额:$39.89万
-
财政年份:2022
-
负责人:SUSAN J SUMNER
-
依托单位:
Untargeted Analysis Resource
-
批准号:10200814
-
项目类别:
-
资助金额:$264.42万
-
财政年份:2019
-
负责人:SUSAN J SUMNER
-
依托单位:
Untargeted Analysis Resource
-
批准号:9814483
-
项目类别:
-
资助金额:$147.41万
-
财政年份:2019
-
负责人:SUSAN J SUMNER
-
依托单位:
Administrative Core/BURGESS
-
批准号:8534956
-
项目类别:
-
资助金额:$25.03万
-
财政年份:2012
-
负责人:SUSAN J SUMNER
-
依托单位:
Promotion and Outreach Core
-
批准号:8535578
-
项目类别:
-
资助金额:$28.29万
-
财政年份:2012
-
负责人:SUSAN J SUMNER
-
依托单位:
MS Metabolomics GC Core/RAYMER
-
批准号:8534957
-
项目类别:
-
资助金额:$24.17万
-
财政年份:2012
-
负责人:SUSAN J SUMNER
-
依托单位:
Eastern Regional Comprehensive Metabolomics Resource Core
-
批准号:9452800
-
项目类别:
-
资助金额:$47.42万
-
财政年份:2012
-
负责人:SUSAN J SUMNER
-
依托单位:
RTI's Regional Comprehensive Metabolomics Resource Center
-
批准号:8894895
-
项目类别:
-
资助金额:$5.0万
-
财政年份:2012
-
负责人:SUSAN J SUMNER
-
依托单位:
RTI's Regional Comprehensive Metabolomics Resource Center
-
批准号:9327565
-
项目类别:
-
资助金额:$5.0万
-
财政年份:2012
-
负责人:SUSAN J SUMNER
-
依托单位:
RTI's Regional Comprehensive Metabolomics Resource Center
-
批准号:8427473
-
项目类别:
-
资助金额:$216.34万
-
财政年份:2012
-
负责人:SUSAN J SUMNER
-
依托单位:
Eastern Regional Comprehensive Metabolomics Resource Core
-
批准号:9414223
-
项目类别:
-
资助金额:$88.81万
-
财政年份:2012
-
负责人:SUSAN J SUMNER
-
依托单位:
LC/MS Metabolomics Core/THOMAS
-
批准号:8534955
-
项目类别:
-
资助金额:$115.49万
-
财政年份:2012
-
负责人:SUSAN J SUMNER
-
依托单位:
RTI's Regional Comprehensive Metabolomics Resource Center
-
批准号:8539790
-
项目类别:
-
资助金额:$228.51万
-
财政年份:2012
-
负责人:SUSAN J SUMNER
-
依托单位:
RTI's Regional Comprehensive Metabolomics Resource Center
-
批准号:8731874
-
项目类别:
-
资助金额:$208.26万
-
财政年份:2012
-
负责人:SUSAN J SUMNER
-
依托单位:
Project 2 Pharmacokinetics and Pharmacodynamics of C60 and MWCNTs in non-pregnant
-
批准号:8066894
-
项目类别:
-
资助金额:$43.62万
-
财政年份:2010
-
负责人:SUSAN J SUMNER
-
依托单位:
Metabolomics: Markers of Drug-Induced Liver Injury(RMI)
-
批准号:7012568
-
项目类别:
-
资助金额:$44.88万
-
财政年份:2005
-
负责人:SUSAN J SUMNER
-
依托单位:
Metabolomics: Markers of Drug-Induced Liver Injury
-
批准号:7140610
-
项目类别:
-
资助金额:$43.82万
-
财政年份:2005
-
负责人:SUSAN J SUMNER
-
依托单位:
Metabolomics: Markers of Drug-Induced Liver Injury(RMI)
-
批准号:7479099
-
项目类别:
-
资助金额:$41.74万
-
财政年份:2005
-
负责人:SUSAN J SUMNER
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
芹菜素通过AGE-RAGE通路抑制干眼的炎症与氧化应激
-
批准号:82505677
-
项目类别:青年科学基金项目(C类)
-
资助金额:30.00万元
-
批准年份:2025
-
负责人:吕雨霏
-
依托单位:
麝香通心滴丸通过干预AGE-RAGE轴调节O-GlcNAc修饰发挥防治DCM作用的药效物质及机制研究
-
批准号:82574874
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2025
-
负责人:刘天华
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位: